RDY 6-K
Dr Reddys Laboratories Ltd (RDY)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGNPRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
October, 2024
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.
EXHIBITS
| Exhibit Number | Description of Exhibits |
|---|---|
| 99.1 | Intimation dated October 4, 2024 |
| 2 |
| --- |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| DR. REDDY’S LABORATORIES LIMITED<br><br> <br>(Registrant) | |||
|---|---|---|---|
| Date: October 4, 2024 | By: | /s/ K Randhir Singh | |
| Name: | K Randhir Singh | ||
| Title: | Company Secretary |
| 3 |
| --- |
Exhibit 99.1
| Dr. Reddy’s Laboratories Ltd.<br><br> <br>8-2-337, Road No. 3, Banjara Hills,<br><br> <br>Hyderabad - 500 034, Telangana,<br><br> <br>India.<br><br> <br>CIN : L85195TG1984PLC004507<br><br> <br>****<br><br> <br>Tel : +91 40 4900 2900<br><br> <br>Fax : +91 40 4900 2999<br><br> <br>Email : [email protected]<br><br> <br>www.drreddys.com |
|---|
October 04, 2024
National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/Madam,
| Sub: | Fixation of Record date for Sub-division / split of the Equity shares of the Company pursuant to Regulation42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
|---|
This is to inform you that the Company has fixed Monday, October 28, 2024 as the “Record Date” for determining entitlement of Equity Shareholders for the purpose of sub-division/ split of each equity share of Rs. 5/- (Rupees five only) each, fully paid-up into 5 (five) equity shares of Re. 1/- (Rupee one only) each, fully paid-up, as approved by the Members of the Company through Postal Ballot on September 12, 2024, and intimated to the Stock Exchanges vide our letter dated September 12, 2024.
Intimation of the aforesaid Record Date as per the prescribed format is enclosed with this letter.
This is for your information and records.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer &Head-CSR
Encl.: as above
| Dr. Reddy’s Laboratories Ltd.<br><br> <br>8-2-337, Road No. 3, Banjara Hills,<br><br> <br>Hyderabad - 500 034, Telangana,<br><br> <br>India.<br><br> <br>CIN : L85195TG1984PLC004507<br><br> <br>****<br><br> <br>Tel : +91 40 4900 2900<br><br> <br>Fax : +91 40 4900 2999<br><br> <br>Email : [email protected]<br><br> <br>www.drreddys.com |
|---|
October 04, 2024
National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
National Securities Depository Limited
Central Depository Services (India) Limited
Bigshare Services Private Limited (Registrar & Share Transfer Agent)
| Sub: | Record Date for determining entitlement of the Equity Shareholders for the purpose of sub-division/split of the Equity Shares of the Company |
|---|
Dear Sir/Madam,
Furnished below is the Record Date as per the prescribed format, for determining entitlement of the Equity Shareholders for the purpose of sub-division/ split of the Equity Shares of the Company:
Name of the Company: Dr. Reddy’s Laboratories Limited
| SECURITY CODE | TYPE OF SECURITY AND PAID UP VALUE | RECORD DATE | PURPOSE |
|---|---|---|---|
| NSE: DRREDDY-EQ<br><br> <br>BSE: 500124<br><br> <br><br><br> <br>NYSE: RDY<br><br> <br><br><br> <br>NSE IFSC: DRREDDY | EQUITY SHARES<br><br> <br><br><br> <br>As on date, total paid-up capital is Rs.<br>834,384,730/- (Rs. 5/- per equity share) | Monday,<br><br> <br><br><br> <br>October 28, 2024 | Determining entitlement of Equity Shareholders<br>for the purpose of sub-division/ split of each equity share of Rs. 5/- (Rupees five only) each, fully paid-up into 5 (five) equity shares<br>of Re. 1/- (Rupee one only) each, fully paid-up. |
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer &Head-CSR